Larimar Therapeutics所有資訊

Larimar Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Blue Owl Capital Holdings LP(6.53%)

11/14 17:11 (美東)

Larimar Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Janus Henderson Group plc(8.7%),Janus Henderson Biotech Innovation Master Fund Ltd(7.5%)

11/14 11:46 (美東)

Larimar Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Verition Fund Management LLC(0.9%),Nicholas Maounis(0.9%)

11/14 09:22 (美東)

Larimar Therapeutics | SC 13G：超過5%持股股東披露文件-THE GOLDMAN SACHS GROUP, INC.(7.0 %),GOLDMAN SACHS & CO. LLC(7.0 %)

11/06 14:32 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 Flynn James E

06/03 18:36 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 Hamilton Thomas Edward

05/31 17:00 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 Truitt Joseph

05/31 17:00 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 SHERMAN JEFFREY W

05/31 17:00 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 LEFF JONATHAN S

05/31 17:00 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 THOMAS FRANK E

05/31 17:00 (美東)

Larimar Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Deerfield Management Company, L.P.(33.32%),James E. Flynn(33.32%)等

03/15 16:42 (美東)

Larimar Therapeutics | SC 13G：超過5%持股股東披露文件-RA Capital Management, L.P.(9.5%),Peter Kolchinsky(9.5%)等

02/26 16:24 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 Flynn James E

02/16 14:42 (美東)

Larimar Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Deerfield Management Company, L.P.(34.82%),James E. Flynn(34.82%)等

02/16 14:17 (美東)

Larimar Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Deerfield Management Company, L.P.(39.20%),James E. Flynn(39.20%)等

02/15 17:24 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 THOMAS FRANK E

02/15 16:25 (美東)

Larimar Therapeutics | SC 13G：超過5%持股股東披露文件-Blue Owl Capital Holdings LP(7.78%)

02/14 21:03 (美東)

Larimar Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(0%),Joseph Edelman(0%)等

02/14 16:51 (美東)

Larimar Therapeutics | SC 13G：超過5%持股股東披露文件-Verition Fund Management LLC(6.4%),Nicholas Maounis(6.4%)

02/14 08:57 (美東)

Larimar Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Janus Henderson Group plc(6.0%),Janus Henderson Biotech Innovation Master Fund Ltd(6.0%)

02/13 17:38 (美東)